Cover Image
市場調查報告書

肌肉骨骼系統相關的各種合作契約:契約條件·協定內容

Global Musculoskeletal Partnering 2010-2016: Deal trends, players and financials

出版商 Current Partnering, a division of Wildwood Ventures Limited 商品編碼 250965
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
肌肉骨骼系統相關的各種合作契約:契約條件·協定內容 Global Musculoskeletal Partnering 2010-2016: Deal trends, players and financials
出版日期: 2016年09月01日 內容資訊: 英文
簡介

本報告提供的肌肉骨骼系統相關各種合作契約相關調查分析,提供近幾年的各種契約趨勢,大規模契約及大醫藥品經營者的契約概要,契約區分·現開發階段·技術區分·各種類適應症的名錄等彙整資料,為您概述為以下內容。

摘要整理

第1章 簡介

第2章 肌肉骨骼系統相關的契約動向

  • 簡介
  • 長期契約
  • 大型製藥企業的肌肉骨骼系統的契約活動
  • 對肌肉骨骼系統的合作態度消極的大型製藥企業
  • 各類型契約
  • 各產業領域
  • 各開發階段
  • 各技術類型
  • 不同症狀
  • 平均契約期間

第3章 主要契約

  • 簡介
  • 主要契約:不同金額契約
  • 大製藥相關的主要契約

第4章 大型製藥企業的肌肉骨骼系統相關的各種契約

  • 簡介
  • 大企業的合作交易的利用方法
  • 企業簡介

第5章 肌肉骨骼系統的合作契約名錄

  • 簡介
  • 各類型契約
  • 各開發階段
  • 各技術類型

第6章 肌肉骨骼系統的契約:不同症狀

  • 簡介
  • 契約:治療指標別
    • 肌肉骨骼系統
    • 關節炎
    • 骨性關節炎
    • 乾癬性關節炎
    • 類風濕關節炎
    • 骨折
    • 痛風
    • 背痛
    • 骨痛
    • 肌肉痛
    • 剛性
    • 骨質疏鬆症
    • 柏哲氏病
    • 脊髓性肌萎縮症

第7章 合作資源中心

  • 線上合作
  • 合作活動
  • 參考資料

附錄

關於Wildwood Ventures

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: CP2215

‘Global Musculoskeletal Partnering 2010-2016: Deal trends, players and financials’ provides comprehensive understanding and unprecedented access to the musculoskeletal partnering deals and agreements entered into by the worlds leading healthcare companies

‘Global Musculoskeletal Partnering 2010 to 2016’ provides the full collection of Musculoskeletal disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

  • Trends in Musculoskeletal partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Musculoskeletal partnering agreement structure
  • Musculoskeletal partnering contract documents
  • Top Musculoskeletal deals by value
  • Most active Musculoskeletal dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Musculoskeletal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Musculoskeletal deals.

The report presents financial deal terms values for Musculoskeletal deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Musculoskeletal dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Musculoskeletal dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Musculoskeletal deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Musculoskeletal dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Musculoskeletal deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Musculoskeletal partnering deals by specific Musculoskeletal target announced since 2010. The chapter is organized by specific Musculoskeletal therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Musculoskeletal partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Musculoskeletal partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Musculoskeletal technologies and products.

Report scope

‘Global Musculoskeletal Partnering 2010 to 2016’ is intended to provide the reader with an in-depth understanding and access to Musculoskeletal trends and structure of deals entered into by leading companies worldwide.

Global Musculoskeletal Partnering 2010 to 2016 includes:

  • Trends in Musculoskeletal dealmaking in the biopharma industry since 2010
  • Analysis of Musculoskeletal deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Musculoskeletal deal contract documents
  • Comprehensive access to over 3500 Musculoskeletal deal records
  • The leading Musculoskeletal deals by value since 2010
  • Most active Musculoskeletal dealmakers since 2010
  • The report includes deals for the following indications: Arthritis, Ankylosing spondylitis, Juvenile arthritis, Osteoarthritis, Psoriatic arthriti, Rheumatoid arthritis, Bone fracture, Hip, Carpel tunnel syndrome, Frozen shoulder, Gout, Knee, Meniscus damage, Muscular dystrophy, Osteoporosis, Paget's disease, Spinal muscular atrophy, Bone pain, Back pain, Muscular pain, Stiffness, Weakness, plus other musculoskeletal indications.

In ‘Global Musculoskeletal Partnering 2010 to 2016’, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The ‘Global Musculoskeletal Partnering 2010-2016’ report provides comprehensive access to available deals and contract documents for over 600 musculoskeletal deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

‘Global Musculoskeletal Partnering 2010 to 2016’ provides the reader with the following key benefits:

  • In-depth understanding of Musculoskeletal deal trends since 2010
  • Access Musculoskeletal deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Musculoskeletal partner companies
  • Comprehensive access to over 750 links to actual Musculoskeletal deals entered into by the world's biopharma companies
  • Indepth review of Musculoskeletal deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Musculoskeletal opportunities
  • Uncover companies actively partnering Musculoskeletal opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Musculoskeletal dealmaking

  • 2.1. Introduction
  • 2.2. Musculoskeletal partnering over the years
  • 2.3. Musculoskeletal partnering by deal type
  • 2.4. Musculoskeletal partnering by industry sector
  • 2.5. Musculoskeletal partnering by stage of development
  • 2.6. Musculoskeletal partnering by technology type
  • 2.7. Musculoskeletal partnering by therapeutic indication

Chapter 3 -Financial deal terms for Musculoskeletal partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Musculoskeletal partnering
  • 3.3. Musculoskeletal partnering headline values
  • 3.4. Musculoskeletal deal upfront payments
  • 3.5. Musculoskeletal deal milestone payments
  • 3.6. Musculoskeletal royalty rates

Chapter 4 - Leading Musculoskeletal deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Musculoskeletal partnering
  • 4.3. List of most active dealmakers in Musculoskeletal
  • 4.4. Top Musculoskeletal deals by value

Chapter 5 - Musculoskeletal contract document directory

  • 5.1. Introduction
  • 5.2. Musculoskeletal partnering deals where contract document available

Chapter 6 - Musculoskeletal dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Musculoskeletal therapeutic target

Appendices

  • Appendix 1 - Directory of Musculoskeletal deals by company A-Z 2010 to 2016
  • Appendix 2 - Directory of Musculoskeletal deals by deal type 2010 to 2016
  • Appendix 3 - Directory of Musculoskeletal deals by stage of development 2010 to 2016
  • Appendix 4 - Directory of Musculoskeletal deals by technology type 2010 to 2016
  • Further reading on dealmaking
  • Deal type definitions

About Wildwood Ventures

  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering

Table of figures

  • Figure 1: Musculoskeletal partnering since 2010
  • Figure 2: Musculoskeletal partnering by deal type since 2010
  • Figure 3: Musculoskeletal partnering by industry sector since 2010
  • Figure 4: Musculoskeletal partnering by stage of development since 2010
  • Figure 5: Musculoskeletal partnering by technology type since 2010
  • Figure 6: Musculoskeletal partnering by indication since 2010
  • Figure 7: Musculoskeletal deals with a headline value
  • Figure 8: Musculoskeletal deals with upfront payment values
  • Figure 9: Musculoskeletal deals with milestone payment
  • Figure 10: Musculoskeletal deals with royalty rates
  • Figure 11: Active Musculoskeletal dealmaking activity- 2010 to 2016
  • Figure 12: Top Musculoskeletal deals by value since 2010
Back to Top